Immunotec Inc (IMMTF) 0.2575 $IMMTF
Immunotec Announces the Nomination of Mario Paradis to its Board of Directors and Reports AGM Results
Marketwire Canada - Thu Apr 28, 7:55AM CDT
Immunotec Inc. (TSX VENTURE:IMM), a direct-to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec"
, today reported the results of its Annual General Meeting of Shareholders held on April 27, 2016 ("AGM".
IMM.VN: 0.345 (-0.020)
Immunotec Renews Material Contract With Glanbia Nutritionals
Marketwired - Fri Apr 08, 3:06PM CDT
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec", is pleased to announce the renewal, for a five (5) year period, of its Supply and Manufacturing Agreement with Glanbia Nutritionals ("Glanbia". This new contract replaces the previous agreement signed in May 2011.
IMM.VN: 0.345 (-0.020)
Immunotec Reports First Quarter Results
Marketwire Canada - Wed Mar 30, 4:01PM CDT
Immunotec Inc. (TSX VENTURE:IMM), a direct-to- consumer company and leader in the nutritional industry (the "Company" or "Immunotec", today announced its first quarter financial results for Fiscal 2016. All amounts in this press release are denominated in Canadian dollars unless otherwise indicated.
IMM.VN: 0.345 (-0.020)
Immunotec Announces Issuance of Bonus Shares
Marketwired - Tue Feb 02, 3:06PM CST
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec", today announced that pursuant to the Immunotec Management Incentive Plan ("MIP", executives, employees and a consultant ("Eligible Employees" were granted an aggregate of 473,750 Common Shares of Immunotec in partial payment of bonuses ("Bonus Shares" for the 2015 financial year; 255,825 of these Bonus Shares were issued to officers of the Corporation.
IMM.VN: 0.345 (-0.020)
Immunotec Reports 2015 Year-End Results
Marketwired - Thu Jan 28, 4:35PM CST
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec", today announced its fourth quarter and year- end consolidated financial results for Fiscal 2015. All amounts in this press release are denominated in Canadian dollars unless otherwise indicated.
IMM.VN: 0.345 (-0.020)
Immunotec Reports Issuance of Options
Marketwired - Tue Sep 22, 7:56AM CDT
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec", today announced that pursuant to the Immunotec Stock Option Plan, an officer was granted options entitling him to acquire up to 100,000 common shares of the Company (the "Shares". The exercise price of such options was established at $0.265, which is the closing price of the Shares on the TSX Venture Exchange the day before their issuance. These options will vest over a three-year period, with one-third (1/3) which will vest on each of the first, second and third anniversaries of the date of the grant. Each option is exercisable, once vested, for a period of five years from the date of grant.
IMM.VN: 0.345 (-0.020)
Immunotec Reports Third Quarter Results
Marketwired - Thu Sep 17, 9:47AM CDT
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec", today announced its consolidated financial results for the third quarter of Fiscal 2015. All amounts in this press release are denominated in Canadian dollars unless otherwise indicated.
IMM.VN: 0.345 (-0.020)
Immunotec Resolves Taxation Matters in Mexico
Marketwired - Tue Jul 21, 3:06PM CDT
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec", reports reaching a Conclusive Agreement ("the Agreement" with both tax authorities Procuraduria de la Defensa del Contribuyente ("PRODECON" and Servicio Administracion Tributaria ("SAT" in regard to the Company's Mexican subsidiary's imports into Mexico.
IMM.VN: 0.345 (-0.020)
Immunotec Obtains $2,780,000 of New Financing
Marketwired - Mon Jul 20, 3:06PM CDT
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec", announces that it has obtained additional financing from the Toronto Dominion Bank ("TD Bank" and a new credit facility from Export Development Canada ("EDC".
IMM.VN: 0.345 (-0.020)
Immunotec Reports Second Quarter Results
Marketwired - Fri Jun 12, 4:45PM CDT
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec", today announced its consolidated financial results for the second quarter of Fiscal 2015. All amounts in this press release are denominated in Canadian dollars unless otherwise indicated.
IMM.VN: 0.345 (-0.020)
Immunotec Announces the Nomination of Mario Paradis to its Board of Directors and Reports AGM Results
Marketwire Canada - Thu Apr 28, 7:55AM CDT
Immunotec Inc. (TSX VENTURE:IMM), a direct-to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec"
, today reported the results of its Annual General Meeting of Shareholders held on April 27, 2016 ("AGM". IMM.VN: 0.345 (-0.020)
Immunotec Renews Material Contract With Glanbia Nutritionals
Marketwired - Fri Apr 08, 3:06PM CDT
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec"
, is pleased to announce the renewal, for a five (5) year period, of its Supply and Manufacturing Agreement with Glanbia Nutritionals ("Glanbia". This new contract replaces the previous agreement signed in May 2011. IMM.VN: 0.345 (-0.020)
Immunotec Reports First Quarter Results
Marketwire Canada - Wed Mar 30, 4:01PM CDT
Immunotec Inc. (TSX VENTURE:IMM), a direct-to- consumer company and leader in the nutritional industry (the "Company" or "Immunotec"
, today announced its first quarter financial results for Fiscal 2016. All amounts in this press release are denominated in Canadian dollars unless otherwise indicated. IMM.VN: 0.345 (-0.020)
Immunotec Announces Issuance of Bonus Shares
Marketwired - Tue Feb 02, 3:06PM CST
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec"
, today announced that pursuant to the Immunotec Management Incentive Plan ("MIP", executives, employees and a consultant ("Eligible Employees" were granted an aggregate of 473,750 Common Shares of Immunotec in partial payment of bonuses ("Bonus Shares" for the 2015 financial year; 255,825 of these Bonus Shares were issued to officers of the Corporation. IMM.VN: 0.345 (-0.020)
Immunotec Reports 2015 Year-End Results
Marketwired - Thu Jan 28, 4:35PM CST
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec"
, today announced its fourth quarter and year- end consolidated financial results for Fiscal 2015. All amounts in this press release are denominated in Canadian dollars unless otherwise indicated. IMM.VN: 0.345 (-0.020)
Immunotec Reports Issuance of Options
Marketwired - Tue Sep 22, 7:56AM CDT
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec"
, today announced that pursuant to the Immunotec Stock Option Plan, an officer was granted options entitling him to acquire up to 100,000 common shares of the Company (the "Shares". The exercise price of such options was established at $0.265, which is the closing price of the Shares on the TSX Venture Exchange the day before their issuance. These options will vest over a three-year period, with one-third (1/3) which will vest on each of the first, second and third anniversaries of the date of the grant. Each option is exercisable, once vested, for a period of five years from the date of grant. IMM.VN: 0.345 (-0.020)
Immunotec Reports Third Quarter Results
Marketwired - Thu Sep 17, 9:47AM CDT
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec"
, today announced its consolidated financial results for the third quarter of Fiscal 2015. All amounts in this press release are denominated in Canadian dollars unless otherwise indicated. IMM.VN: 0.345 (-0.020)
Immunotec Resolves Taxation Matters in Mexico
Marketwired - Tue Jul 21, 3:06PM CDT
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec"
, reports reaching a Conclusive Agreement ("the Agreement" with both tax authorities Procuraduria de la Defensa del Contribuyente ("PRODECON" and Servicio Administracion Tributaria ("SAT" in regard to the Company's Mexican subsidiary's imports into Mexico. IMM.VN: 0.345 (-0.020)
Immunotec Obtains $2,780,000 of New Financing
Marketwired - Mon Jul 20, 3:06PM CDT
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec"
, announces that it has obtained additional financing from the Toronto Dominion Bank ("TD Bank" and a new credit facility from Export Development Canada ("EDC". IMM.VN: 0.345 (-0.020)
Immunotec Reports Second Quarter Results
Marketwired - Fri Jun 12, 4:45PM CDT
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec"
, today announced its consolidated financial results for the second quarter of Fiscal 2015. All amounts in this press release are denominated in Canadian dollars unless otherwise indicated. IMM.VN: 0.345 (-0.020)
